You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysis
|
|---|---|
| Published in |
BMC Neurology, May 2012
|
| DOI | 10.1186/1471-2377-12-30 |
| Pubmed ID | |
| Authors |
Syed Nabeel Zafar, Abdul Ahad Khan, Asfar Ayaz Ghauri, Muhammad Shahzad Shamim |
| Abstract |
Current standard therapy for seizure prophylaxis in Neuro-surgical patients involves the use of Phenytoin (PHY). However, a new drug Levetiracetam (LEV) is emerging as an alternate treatment choice. We aimed to conduct a meta-analysis to compare these two drugs in patients with brain injury. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 17% |
| Mexico | 1 | 17% |
| Spain | 1 | 17% |
| Egypt | 1 | 17% |
| Unknown | 2 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 174 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 2% |
| Australia | 2 | 1% |
| Colombia | 1 | <1% |
| Brazil | 1 | <1% |
| Ethiopia | 1 | <1% |
| Spain | 1 | <1% |
| Iran, Islamic Republic of | 1 | <1% |
| Unknown | 164 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 26 | 15% |
| Student > Bachelor | 21 | 12% |
| Student > Postgraduate | 18 | 10% |
| Other | 15 | 9% |
| Student > Master | 14 | 8% |
| Other | 45 | 26% |
| Unknown | 35 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 96 | 55% |
| Neuroscience | 12 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 6% |
| Agricultural and Biological Sciences | 4 | 2% |
| Nursing and Health Professions | 3 | 2% |
| Other | 11 | 6% |
| Unknown | 38 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2016.
All research outputs
#6,582,815
of 23,443,716 outputs
Outputs from BMC Neurology
#766
of 2,503 outputs
Outputs of similar age
#45,554
of 166,487 outputs
Outputs of similar age from BMC Neurology
#13
of 31 outputs
Altmetric has tracked 23,443,716 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 2,503 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,487 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.